— Know what they know.
Not Investment Advice

PACS NYSE

PACS Group, Inc.
1W: +6.3% 1M: +18.0% 3M: +3.8% YTD: +23.4% 1Y: +282.6%
$47.85
-0.91 (-1.86%)
After Hours: $47.90 (+0.05, +0.10%)
Weekly Expected Move ±5.5%
$42 $45 $48 $50 $53
NYSE · Healthcare · Medical - Care Facilities · Tech Score Strong Buy · Power 74 · $7.7B mcap · 49M float · 1.73% daily turnover · Short 57% of daily vol
Credit Risk of going bust: higher than 53% of companies Debt: 29.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.26 (down 99.5%), PACS Group, Inc. would be worth roughly what it owes.
Total debt $3.25B against a stock market value of $7.72B.
Distance to default 4.83 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $126.7M (short-term plus half of long-term), stock volatility 81.0%; Altman Z'' 0.91. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
46.5 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 6.9%
Cost Advantage ★
56
Intangibles
51
Switching Cost
45
Network Effect
27
Scale
48
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PACS shows a Weak competitive edge (46.5/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 6.9% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$60
Low
$61
Avg Target
$62
High
Based on 2 analysts since Aug 4, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$61.00
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-02 Truist Financial David MacDonald $52 $62 +10 +44.2% $43.00
2026-08-06 UBS — $57 $60 +3 +23.6% $48.53
2026-07-08 UBS — $42 $57 +15 +26.4% $45.10
2026-05-18 Truist Financial — $40 $52 +12 +37.0% $37.96
2026-05-13 Oppenheimer Michael Wiederhorn $40 $48 +8 +17.0% $41.01
2026-03-02 RBC Capital Ben Hendrix $47 $52 +5 +38.9% $37.45
2025-12-19 RBC Capital Ben Hendrix $33 $47 +14 +28.7% $36.52
2025-12-18 UBS — Initiated $42 — +21.1% $34.68
2025-12-12 Truist Financial — $44 $40 -4 +18.0% $33.88
2025-11-20 RBC Capital — $30 $33 +3 +30.4% $25.31
2024-08-15 Truist Financial David MacDonald $32 $44 +12 +15.4% $38.13
2024-08-13 Oppenheimer Michael Wiederhorn $32 $40 +8 +23.6% $32.35
2024-06-27 Macquarie Tao Qiu Initiated $35 — +15.9% $30.19
2024-05-15 Oppenheimer Michael Wiederhorn $31 $32 +1 +18.9% $26.91
2024-05-06 Truist Financial David MacDonald Initiated $32 — +29.0% $24.81
2024-05-06 Oppenheimer Michael Wiederhorn Initiated $31 — +24.9% $24.81
2024-05-06 RBC Capital Ben Hendrix Initiated $30 — +20.9% $24.81

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 27, 2026
DCF
3
ROE
5
ROA
4
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PACS receives an overall rating of B. Strongest factors: ROE (5/5), ROA (4/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-12 B+ B
2026-10-01 B B+
2026-08-13 B+ B
2026-07-01 B B+
2026-07-01 B+ B
2026-06-02 B B+
2026-06-01 B+ B
2026-05-18 B B+
2026-04-02 B+ B
2026-04-01 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 56 Grade C
Profitability
41
Balance Sheet
34
Earnings Quality
76
Growth
71
Value
46
Momentum
94
Safety
50
Cash Flow
51
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PACS scores highest in Momentum (94/100) and lowest in Balance Sheet (34/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.23
Grey Zone
Piotroski F-Score
8/9
✓ ✓ ✓ ✓ ✓ ✗ ✓ ✓ ✓
Beneish M-Score
-2.65
Unlikely Manipulator
Ohlson O-Score
-6.03
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BBB-
Score: 51.4/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 2.13x
Accruals: -5.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PACS scores 2.23, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PACS scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PACS's score of -2.65 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PACS's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PACS receives an estimated rating of BBB- (score: 51.4/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). PACS's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
28.03x
PEG
0.28x
P/S
1.36x
P/B
6.79x
P/FCF
17.59x
P/OCF
12.05x
EV/EBITDA
20.82x
EV/Revenue
1.80x
EV/EBIT
24.25x
EV/FCF
25.45x
Earnings Yield
3.90%
FCF Yield
5.68%
Shareholder Yield
0.49%
Graham Number
$16.01
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 28.0x earnings, PACS commands a growth premium. Graham's intrinsic value formula yields $16.01 per share, 205% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.703
NI / EBT
×
Interest Burden
0.929
EBT / EBIT
×
EBIT Margin
0.074
EBIT / Rev
×
Asset Turnover
0.995
Rev / Assets
×
Equity Multiplier
5.820
Assets / Equity
=
ROE
28.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PACS's ROE of 28.1% is driven by financial leverage (equity multiplier: 5.82x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$63.98
Price/Value
0.67x
Margin of Safety
33.35%
Premium
-33.35%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with PACS's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. PACS trades at a -33% premium to its adjusted intrinsic value of $63.98, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 28.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 639 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$47.83
Median 1Y
$47.25
5th Pctile
$13.28
95th Pctile
$167.53
Ann. Volatility
77.9%
Analyst Target
$61.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Jason Murray Director,
Co-Founder, Chief Executive Officer and Chairman
$500,000 $8,358,504 $17,071,124
Josh Jergensen Operating
and Chief Operating Officer
$524,600 $7,491,504 $16,375,582
Mark Hancock Director,
Co-Founder, Executive Vice Chairman and former interim Chief Financial Officer
$500,000 $6,624,504 $15,337,124
John Mitchell Legal
Legal Officer and Secretary
$424,600 $4,225,931 $9,645,521
Michelle Lewis Accounting
unting Officer
$446,624 $1,790,424 $6,594,180
Derick Apt Financial
ief Financial Officer
$404,882 $— $4,251,653

CEO Pay Ratio

2268:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $17,071,124
Avg Employee Cost (SGA/emp): $7,526
Employees: 45,680

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
45,680
Revenue / Employee
$89,530
Rev: $4,089,734,000
Profit / Employee
$1,221
NI: $55,760,000
SGA / Employee
$7,526
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -1.9% 0.7% 5.9% 9.4% 19.2% 22.1% 23.1% 27.3% 28.1% 28.08%
ROA -0.3% 0.1% 0.8% 1.3% 2.8% 3.3% 3.5% 4.4% 4.8% 4.82%
ROIC 0.0% 0.2% 1.3% 2.1% 3.6% 5.0% 5.3% 6.3% 6.9% 6.88%
ROCE -0.1% 1.0% 2.6% 2.5% 2.6% 3.5% 3.9% 6.5% 9.0% 8.96%
Gross Margin 15.7% 10.1% 14.4% 19.8% 22.0% 22.2% 16.5% 16.4% 23.7% 23.70%
Operating Margin 0.1% 2.2% 6.0% 3.8% 6.1% 6.4% 7.0% 8.5% 7.7% 7.66%
Net Margin -1.1% 1.5% 3.1% 2.2% 3.9% 3.9% 4.4% 5.7% 5.3% 5.35%
EBITDA Margin 0.6% 5.2% 6.9% 1.0% 1.0% 7.4% 8.2% 9.7% 9.2% 9.24%
FCF Margin 2.0% 8.1% 4.5% 6.2% 8.4% 8.7% 6.6% 7.9% 7.1% 7.07%
OCF Margin 3.5% 12.2% 9.6% 10.2% 12.3% 11.4% 9.8% 11.2% 10.3% 10.33%
ROE 3Y Avg snapshot only 12.91%
ROA 3Y Avg snapshot only 2.29%
ROIC 3Y Avg snapshot only 3.01%
ROIC Economic snapshot only 6.79%
Cash ROA snapshot only 10.13%
Cash ROIC snapshot only 13.66%
CROIC snapshot only 9.35%
NOPAT Margin snapshot only 5.20%
Pretax Margin snapshot only 6.89%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 7.97%
SBC / Revenue snapshot only 1.81%
Valuation
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -404.14 1344.67 48.54 26.58 16.17 13.38 31.41 21.36 25.66 28.029
P/S Ratio 4.49 3.15 0.63 0.42 0.44 0.44 1.14 0.96 1.24 1.359
P/B Ratio 7.71 9.60 2.87 2.49 2.65 2.60 6.35 5.02 6.22 6.785
P/FCF 226.33 38.90 14.10 6.76 5.29 5.05 17.25 12.09 17.59 17.592
P/OCF 126.65 25.95 6.59 4.08 3.61 3.85 11.58 8.59 12.05 12.049
EV/EBITDA 1263.18 156.08 34.90 31.66 31.58 24.59 38.22 23.04 20.82 20.816
EV/Revenue 7.18 4.57 1.54 1.09 1.06 1.00 1.70 1.53 1.80 1.800
EV/EBIT -2206.51 232.36 45.13 44.58 45.35 33.01 50.03 27.72 24.25 24.249
EV/FCF 361.88 56.36 34.41 17.72 12.69 11.45 25.86 19.33 25.45 25.454
Earnings Yield -0.2% 0.1% 2.1% 3.8% 6.2% 7.5% 3.2% 4.7% 3.9% 3.90%
FCF Yield 0.4% 2.6% 7.1% 14.8% 18.9% 19.8% 5.8% 8.3% 5.7% 5.68%
PEG Ratio snapshot only 0.280
Price/Tangible Book snapshot only 6.627
EV/OCF snapshot only 17.434
EV/Gross Profit snapshot only 9.146
Acquirers Multiple snapshot only 24.356
Shareholder Yield snapshot only 0.49%
Graham Number snapshot only $16.01
Leverage & Solvency
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.71 1.08 0.96 0.98 0.92 0.94 1.07 0.99 0.91 0.912
Quick Ratio 1.71 1.08 0.96 0.98 0.92 0.94 1.07 0.99 0.91 0.912
Debt/Equity 4.74 4.38 4.35 4.43 4.08 3.70 3.38 3.24 2.93 2.928
Net Debt/Equity 4.62 4.31 4.13 4.04 3.71 3.29 3.17 3.01 2.78 2.780
Debt/Assets 0.70 0.64 0.59 0.60 0.60 0.57 0.57 0.59 0.57 0.575
Debt/EBITDA 486.29 49.20 21.71 21.44 20.24 15.45 13.56 9.32 6.77 6.772
Net Debt/EBITDA 473.14 48.35 20.60 19.58 18.43 13.74 12.72 8.63 6.43 6.429
Interest Coverage -0.35 2.17 4.00 3.20 3.83 5.34 6.35 10.77 13.94 13.937
Equity Multiplier 6.81 6.84 7.39 7.32 6.82 6.46 5.90 5.46 5.09 5.094
Cash Ratio snapshot only 0.156
Debt Service Coverage snapshot only 16.236
Cash to Debt snapshot only 0.051
FCF to Debt snapshot only 0.121
Defensive Interval snapshot only 475.2 days
Efficiency & Turnover
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.25 0.44 0.61 0.82 1.03 1.01 0.98 0.97 0.99 0.995
Inventory Turnover — — — — — — — — — —
Receivables Turnover 1.61 3.49 5.01 6.60 7.72 8.54 7.87 8.18 8.72 8.724
Payables Turnover 6.58 11.31 15.90 19.17 26.87 22.90 23.01 23.15 26.78 26.785
DSO 227 104 73 55 47 43 46 45 42 41.8 days
DIO 0 0 0 0 0 0 0 0 0 0.0 days
DPO 55 32 23 19 14 16 16 16 14 13.6 days
Cash Conversion Cycle 172 72 50 36 34 27 31 29 28 28.2 days
Fixed Asset Turnover snapshot only 1.303
Cash Velocity snapshot only 33.755
Capital Intensity snapshot only 1.019
Growth (YoY)
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — 3.9% 1.6% 64.5% 20.9% 15.2% 15.15%
Net Income — — — — 13.1% 34.9% 3.6% 2.5% 1.0% 1.04%
EPS — — — — 11.9% 33.5% 3.5% 2.6% 1.1% 1.08%
FCF — — — — 19.8% 1.8% 1.4% 55.6% -2.9% -2.90%
EBITDA — — — — 28.1% 2.5% 65.9% 1.3% 2.0% 1.95%
Op. Income — — — — 313.9% 11.1% 2.2% 1.7% 83.5% 83.52%
OCF Growth snapshot only -3.18%
Asset Growth snapshot only 2.80%
Equity Growth snapshot only 37.62%
Debt Growth snapshot only -1.14%
Shares Change snapshot only -2.11%
Dividend Growth snapshot only 1.12%
Growth Quality
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — — — 0.87 0.866
Earnings Stability — — — — — — — — 1.00 1.000
Margin Stability — — — — — — — — 0.88 0.883
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 0 0 0 0 1 1 1 1 1 1
Earnings Persistence — — — — — — — — 0.50 0.500
Earnings Smoothness — — — — — 0.00 0.00 0.00 0.32 0.318
ROE Trend — — — — — — — — 0.17 0.170
Gross Margin Trend — — — — — — — — 0.03 0.033
FCF Margin Trend — — — — — — — — 0.02 0.019
Sustainable Growth Rate — -1.7% 3.6% 7.2% 16.8% 15.6% 17.1% 21.7% 24.6% 24.56%
Internal Growth Rate — — 0.5% 1.0% 2.5% 2.4% 2.7% 3.6% 4.4% 4.41%
Cash Flow Quality
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -3.19 51.81 7.36 6.52 4.48 3.48 2.71 2.48 2.13 2.130
FCF/OCF 0.56 0.67 0.47 0.60 0.68 0.76 0.67 0.71 0.68 0.685
FCF/Net Income snapshot only 1.459
OCF/EBITDA snapshot only 1.194
CapEx/Revenue 1.6% 4.0% 5.1% 4.1% 3.9% 2.7% 3.2% 3.2% 3.3% 3.25%
CapEx/Depreciation snapshot only 2.657
Accruals Ratio -0.01 -0.05 -0.05 -0.07 -0.10 -0.08 -0.06 -0.06 -0.05 -0.055
Sloan Accruals snapshot only -0.013
Cash Flow Adequacy snapshot only 2.674
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.4% 0.3% 0.8% 0.9% 0.8% 2.2% 0.8% 1.0% 0.5% 0.00%
Dividend/Share $0.11 $0.10 $0.10 $0.10 $0.10 $0.30 $0.32 $0.31 $0.21 $0.00
Payout Ratio — 3.4% 38.8% 23.1% 12.3% 29.6% 26.1% 20.5% 12.5% 12.53%
FCF Payout Ratio 83.4% 10.0% 11.3% 5.9% 4.0% 11.2% 14.3% 11.6% 8.6% 8.59%
Total Payout Ratio — 10.6% 1.2% 70.8% 37.7% 49.2% 43.4% 34.1% 12.7% 12.69%
Div. Increase Streak 0 0 0 0 0 1 1 1 0 0
Chowder Number — — — — 0.01 2.10 2.08 2.09 1.08 1.080
Buyback Yield 0.8% 0.5% 1.7% 1.8% 1.6% 1.5% 0.6% 0.6% 0.0% 0.01%
Net Buyback Yield 0.8% -1.0% -3.0% -3.3% -2.9% 1.5% 0.6% 0.6% 0.0% 0.01%
Total Shareholder Return 1.1% -0.7% -2.2% -2.4% -2.1% 3.7% 1.4% 1.6% 0.5% 0.49%
DuPont Factors
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.88 0.22 0.51 0.56 0.61 0.65 0.67 0.69 0.70 0.703
Interest Burden (EBT/EBIT) 3.88 0.54 0.75 1.14 1.91 1.67 1.58 1.18 0.93 0.929
EBIT Margin -0.00 0.02 0.03 0.02 0.02 0.03 0.03 0.06 0.07 0.074
Asset Turnover 0.25 0.44 0.61 0.82 1.03 1.01 0.98 0.97 0.99 0.995
Equity Multiplier 6.81 6.84 7.39 7.32 6.82 6.62 6.54 6.24 5.82 5.820
Per Share
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.07 $0.03 $0.27 $0.42 $0.80 $1.03 $1.22 $1.50 $1.66 $1.66
Book Value/Share $3.83 $4.17 $4.57 $4.51 $4.88 $5.29 $6.04 $6.40 $6.85 $7.05
Tangible Book/Share $3.39 $3.75 $4.14 $4.11 $4.47 $4.88 $5.61 $5.98 $6.43 $6.43
Revenue/Share $6.57 $12.67 $20.72 $27.00 $29.13 $31.20 $33.75 $33.52 $34.27 $35.11
FCF/Share $0.13 $1.03 $0.93 $1.66 $2.44 $2.72 $2.23 $2.66 $2.42 $2.88
OCF/Share $0.23 $1.54 $1.99 $2.76 $3.58 $3.57 $3.32 $3.74 $3.54 $3.63
Cash/Share $0.49 $0.31 $1.02 $1.73 $1.78 $2.16 $1.26 $1.53 $1.02 $1.04
EBITDA/Share $0.04 $0.37 $0.92 $0.93 $0.98 $1.27 $1.51 $2.23 $2.96 $2.96
Debt/Share $18.16 $18.25 $19.89 $19.95 $19.87 $19.56 $20.40 $20.76 $20.07 $20.07
Net Debt/Share $17.67 $17.94 $18.88 $18.23 $18.10 $17.40 $19.15 $19.23 $19.05 $19.05
Academic Models
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — 2.230
Altman Z-Prime snapshot only 2.248
Piotroski F-Score 3 4 4 4 7 7 8 8 8 8
Beneish M-Score — — — — -2.68 -2.94 -2.82 -2.63 -2.65 -2.649
Ohlson O-Score snapshot only -6.034
ROIC (Greenblatt) snapshot only 9.89%
Net-Net WC snapshot only $-22.09
EVA snapshot only $-131130428.77
Credit
Metric Trend Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB-
Credit Score 18.40 30.62 26.06 27.35 33.72 37.61 46.43 50.28 51.44 51.437
Credit Grade snapshot only 10
Credit Trend snapshot only 17.715
Implied Spread (bps) snapshot only 350.000
Industry Credit Rank snapshot only 45
Sector Credit Rank snapshot only 45

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms